◆英語タイトル：Genfit SA (GNFT) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011724
◆発行会社（調査会社）：
GlobalData
◆発行日：2017年12月13日
◆ページ数：36
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s product pipeline comprise GFT505, TGFTX1, TGFTX3, TGFTX4, TGFTX5 and SAN/GFT-2. Its TGFTX1 can be used for the treatment of inflammatory and auto-immune diseases; and TGFTX3 for metabolic and inflammatory diseases. Genfit provides TGFTX4 for fibrotic diseases; and TGFTX5 for the treatment of chronic inflammatory bowel diseases. The company’s research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.
Genfit SA (GNFT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genfit SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genfit SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genfit SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genfit SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genfit SA, Medical Equipment, Deal Details 10
Partnerships 10
ImaBiotech Enters Into Agreement With Genfit 10
Equity Offering 11
Genfit Raises USD50 Million in Rights Offering of Shares 11
Genfit Raises USD38 Million Private Placement of Shares 12
Genfit Raises USD54.2 Million in Private Placement of Shares 13
Genfit Raises USD26 Million in Private Placement of Shares 14
Debt Offering 15
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 15
Acquisition 16
Novartis May Acquire Genfit 16
Genfit SA – Key Competitors 17
Genfit SA – Key Employees 18
Genfit SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 11, 2017: GENFIT: Third quarter 2017 financial information 20
Sep 25, 2017: Genfit: 2017 Half-Year Results: Cash Position At End Of Period At €126M And Significant Advances In The Company’S Pipeline 21
Apr 24, 2017: Genfit: Q1 2017 Financial Information 26
Nov 08, 2016: GENFIT: Third Quarter 2016 Financial Information 30
Apr 26, 2016: Genfit: First Quarter 2016 Financial Information 31
Feb 04, 2016: Annual Results 2015: End-Of-Year Cash Position Of €60M And Major Progress In The Diagnosis And The Treatment Of Nash 33
Product News 34
Oct 20, 2016: GENFIT announces the acceptance of two new abstracts, including one to be presented in an oral session at the 2016 AASLD meeting 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Genfit SA, Medical Equipment, Key Facts, 2016 2
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genfit SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genfit SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genfit SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genfit SA, Deals By Market, 2011 to YTD 2017 8
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ImaBiotech Enters Into Agreement With Genfit 10
Genfit Raises USD50 Million in Rights Offering of Shares 11
Genfit Raises USD38 Million Private Placement of Shares 12
Genfit Raises USD54.2 Million in Private Placement of Shares 13
Genfit Raises USD26 Million in Private Placement of Shares 14
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 15
Novartis May Acquire Genfit 16
Genfit SA, Key Competitors 17
Genfit SA, Key Employees 18
Genfit SA, Subsidiaries 19
